Deerfield Management’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-166,666
| Closed | -$55K | – | 133 |
|
|
2025
Q4 | $55K | Hold |
166,666
| – | – | ﹤0.01% | 146 |
|
|
2025
Q3 | $33.7K | Hold |
166,666
| – | – | ﹤0.01% | 147 |
|
|
2025
Q2 | $45K | Hold |
166,666
| – | – | ﹤0.01% | 117 |
|
|
2025
Q1 | $53.3K | Hold |
166,666
| – | – | ﹤0.01% | 113 |
|
|
2024
Q4 | $38.3K | Hold |
166,666
| – | – | ﹤0.01% | 103 |
|
|
2024
Q3 | $16.3K | Hold |
166,666
| – | – | ﹤0.01% | 441 |
|
|
2024
Q2 | $26.7K | Hold |
166,666
| – | – | ﹤0.01% | 429 |
|
|
2024
Q1 | $50.4K | Hold |
166,666
| – | – | ﹤0.01% | 361 |
|
|
2023
Q4 | $10K | Hold |
166,666
| – | – | ﹤0.01% | 219 |
|
|
2023
Q3 | $16.7K | Hold |
166,666
| – | – | ﹤0.01% | 86 |
|
|
2023
Q2 | $27.6K | Hold |
166,666
| – | – | ﹤0.01% | 98 |
|
|
2023
Q1 | $20K | Hold |
166,666
| – | – | ﹤0.01% | 100 |
|
|
2022
Q4 | $24.1K | Hold |
166,666
| – | – | ﹤0.01% | 100 |
|
|
2022
Q3 | $33K | Hold |
166,666
| – | – | ﹤0.01% | 118 |
|
|
2022
Q2 | $47K | Hold |
166,666
| – | – | ﹤0.01% | 116 |
|
|
2022
Q1 | $135K | Hold |
166,666
| – | – | ﹤0.01% | 108 |
|
|
2021
Q4 | $315K | Hold |
166,666
| – | – | 0.01% | 117 |
|
|
2021
Q3 | $427K | Hold |
166,666
| – | – | 0.01% | 125 |
|
|
2021
Q2 | $433K | Hold |
166,666
| – | – | 0.01% | 141 |
|
|
2021
Q1 | $445K | Buy |
+166,666
| New | +$482K | 0.01% | 132 |
|
Deerfield Management's NUVB.WS Position: Q1 2026 in Review
Deerfield Management sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q1 2026, closing a stake of 166,666 shares — an estimated $55K sold.
Deerfield Management first reported a position in NUVB.WS in Q1 2021 and held it in 20 quarters. The position peaked at $445K in Q1 2021. 0 funds tracked by Wall St. Rank hold NUVB.WS as of Q1 2026.
- Deerfield Management reported no remaining Nuvation Bio Inc Warrants position as of Q1 2026 after selling out during the quarter.
- Deerfield Management sold 166,666 Nuvation Bio Inc Warrants shares in Q1 2026, an estimated $55K.
- Deerfield Management first reported a position in Nuvation Bio Inc Warrants in Q1 2021 and held it in 20 quarters.
- Deerfield Management's Nuvation Bio Inc Warrants position peaked at $445K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q1 2026.
Based on Deerfield Management's 13F filing for Q1 2026, filed 15 May 2026.